Pharmafile Logo
Pharmafocus logo
Advanced Search
flu

First novel, single-dose flu drug approved in US in almost 20 years

October 25, 2018
Sales and Marketing FDA, Shionogi, Xofluza, flu, influenza, pharma

The FDA has announced that it has approved the first single-dose flu drug with a novel mechanism of action in …

News
shutterstock_292920209

UCB and Biogen’s lupus drug falls short at Phase 2b

October 24, 2018
Research and Development Biogen, Lupus, UCB, dapirolizumab pegol, pharma, systemic lupus erythematosus, trial falure

The partnership of UCB and Biogen announced disappointing news, confirming that its experimental therapy dapirolizumab pegol (DZP) failed to meet …

News
acute_lymphoblastic_leukaemia_smear

New $2 million programme aims at increasing diversity in cancer research

October 24, 2018
Research and Development Cancer, USA, black, cancer research, diversity, latino, native american

The National Cancer Institute are developing a joint cancer drug discovery and development, and research education programme focused towards the …

News
shutterstock_360472550

Pfizer & Lilly’s non-opioid drug reduces pain in osteoarthritis

October 24, 2018
Research and Development Eli Lilly, Pfizer, osteoarthritis, pharma

Pfizer and Eli Lilly have announced data revealing that their nerve growth factor (NGF) inhibitor tanezumab met all three of …

News
28246711066_52e38bc591_z

Industry leaders warn public may have to stockpile medicines in case of no-deal Brexit

October 24, 2018
Research and Development brexit, no-deal Brexit, stockpiling

Martin Sawer, the executive director of the Healthcare Distribution Association (HDA) – formerly the British Association of Pharmaceutical Wholesalers (BAPW) …

News
tibet-3591529_960_720

Guangdong bans transportation of pigs due to African swine fever outbreak in Hunan

October 23, 2018
Research and Development ASF, African swine fever, China, Guangdong, Hunan, animal health

Chinese authorities have banned the transportation of live pigs from Guangdong to other regions, after reports of African swine fever …

News
roche

Roche’s Alecensa topples Pfizer’s Xalkori in Asian patients with ALK+ advanced lung cancer

October 23, 2018
Manufacturing and Production, Research and Development Alecensa, Cancer, ESMO 2018, Roche, lung cancer, pharma

Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small …

News
merckincweb2

First-line Keytruda shows better overall survival in head & neck cancer

October 23, 2018
Manufacturing and Production, Research and Development Cancer, ESMO 2018, MSD, head and neck cancer, keytruda, pharma

MSD’s Keytruda (pembrolizumab) made an impact at the European Society for Medical Oncology 2018 Congress as the company unveiled new …

News
image_credit_-_rafael_matsunaga

Shares in Mirati plummet after disappointing Phase II trial

October 23, 2018
Manufacturing and Production Cancer, Mirati, leuakemia, plummet, stocks

Shares in the California-based biotech Mirati Therapuetics plummeted on Monday after the company released disappointing results from their Phase II …

News
394px-ad_versus_co

UK Dementia partnership offering £100,000-200,000 awards for dementia research projects

October 23, 2018
Manufacturing and Production Alzheimer's, dementia, development, research

The Dementia Discovery Fund (DDF) in partnership with the UK Dementia Research Institute (UK DRI) has announced that it will …

News

J&J announce promising Phase 1/2a results for HIV vaccine

October 23, 2018
Manufacturing and Production AIDS, HIV, J&J, JJ, Vaccine, infectious diseases

The world may be one step closer to discovering a preventative vaccine for HIV following American multinational Johnson & Johnson’s …

News
roche_dark_0

Roche’s Tecentriq+chemo boosts survival in first-line non-small cell lung cancer

October 22, 2018
Research and Development, Sales and Marketing Cancer, Roche, lung cancer NSCLC, pharma, tecentriq

Roche joined other major players like Bristol-Myers Squibb in revealing strong data on their cancer immunotherapies at the European Society …

News

Working Life: Joe Wiley, CEO, Amryt Pharma

October 22, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, CEO, Ireland, Joe WIley, pharma

Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in …

Feature

Takeda’s subcutaneous vedolizumab proves efficacious in Phase III trial for Ulcerative Colitis

October 22, 2018
Sales and Marketing Takeda, UC, biologic, phase III, results, ulcerative colitis, vedolizumab

Japanese pharma firm Takeda has announced that the gut-selective biologic vedolizumab when taken as a subcutaneous (SC) injection, proved efficacious …

News
janssen_latest_logo_on_sign_closer

Janssen’s Tremfya maintains skin clearance after 3 years in plaque psoriasis

October 22, 2018
Research and Development, Sales and Marketing Janssen, Tremfya, pharma, plaque psoriasis, psoriasis

Janssen has revealed new long-term data for its IL-23 inhibitor Tremfya (guselkumab) in moderate to severe plaque psoriasis, demonstrating skin …

News

BMS’ Opdivo and Yervoy combination shows outstanding survival rate in cancer patients

October 22, 2018
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Yervoy, melanoma, opdivo

American pharma firm Bristol-Myers Squibb have announced that more than 53% of patients with advanced melanoma, who were treated with …

News

GSK named third best UK workplace

October 22, 2018
Sales and Marketing AbbVie, Amgen, BMS, Eli Lilly, GSK, J&J, JJ, work

British multinational GlaxoSmithKline has been rated as the third best company to work for in the UK, according to jobs …

News
merckincweb

MSD’s Keytruda with Pfizer’s Inlyta beats Sutent in most common kidney cancer

October 19, 2018
Medical Communications, Research and Development Cancer, Kidney cancer, MSD, Pfizer, inlyta, keytruda, pharma

MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …

News
5204602349_c87b204860_z

US FDA offers plan for global regulatory harmonisation for generic drugs

October 19, 2018
Medical Communications FDA, ICH, generic drugs, harmonisation, regulatory bodies

The US Food and Drug Administration (FDA) is offering a proposal to the International Council on Harmonisation (ICH) aimed at …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026